2026-03-13 β€’ DoubleBlind Magazine

Inside a Johns Hopkins Study Giving Psilocybin to Lyme Patients

Here's what researchers found after chronic Lyme patients received two doses of psilocybin. [...] Read More... The post Inside a Johns Hopkins Study Giving Psilocybin to Lyme Patients appeared first on DoubleBlind Mag.

External link. We are not responsible for the content.

Read more β†—

More From DoubleBlind Magazine

2026-04-29 β€’ DoubleBlind Magazine

Psychedelics Are Booming, But Who Is Getting Left Out?

This fast-moving renaissance is leaving out key voices, even as many within the psychedelic culture are pushing to br...

2026-04-27 β€’ DoubleBlind Magazine

Rick Doblin Speaks with Protesters About Gaza and MAPS Israel

Plus, executive order details, FDA guidelines for psychedelic research, and psilocybin for weight loss. [...] Read Mo...

2026-04-24 β€’ DoubleBlind Magazine

Fast-Tracking Psychedelic Research May Not Be So Simple

A new federal push promises faster access, but funding gaps, ethical risks, and systemic hurdles remain. [...] Read M...

Latest News

2026-04-28 β€’ Breaking Convention (Substack)

Party, Party Party!

Official After Party, plus more talks announced!

2026-04-28 β€’ Chemical Collective

To What Extent Are Memories of Psychedelic Trips Embellished?

Memory distortion – including embellishment and false memories – is a natural human tendency that applies to psychede...

2026-04-27 β€’ MAPS

Protected: RELOCATING THE ROOT

There is no excerpt because this is a protected post.

2026-04-27 β€’ The Microdose (Berkeley)

What do police think about psychedelic therapy? 5 Questions for psychologist Alexandra Hopkins

Hopkins discusses her work on the perspectives of military and law enforcement.

2026-04-27 β€’ Psychedelics Today

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Aspen Psychedelic Symposium is the focus of this conversation with Martha Hammel of the Aspen Psychedelic Resource Ce...

2026-04-27 β€’ Chemical Collective

PSYCH NEWS – 27/04/2026

April 2026 marked a watershed moment for psychedelic therapy, with Trump fast-tracking research and patient access, C...